This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
We are very excited to launch our new website! Please take a few moments to click around and explore...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...
Beginning June 1, 2020 all 5 CTS laboratories will being transitioning from the Grifols Procleix Ult...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...